Is Bicara Therapeutics Inc. Common Stock (BCAX) a Buy, Sell, or Hold?
NASDAQ : BCAX
Bicara Therapeutics Inc. Common Stock — Institutional Ownership
$26.88 USD
-$0.93 (-3.34%)
- Volume
- 457.09K
- Average Volume
- 672.01K
- Market Capitalization
- $1.47B
- P/E Ratio
- -9.67
- Dividend Yield
- 0.00%
- Price Target
- $37.00
- Year High
- $30.99
- Year Low
- $9.57
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $13.85
Institutional Ownership Summary
Institutional Ownership %
6.20%
Investors Holding
16
change: -138 | last: 154
Increased Positions
5
change: -85 | last: 90
Reduced Positions
6
change: -34 | last: 40
New Positions
2
change: -28 | last: 30
Sold Positions
134
change: 111 | last: 23
Total Calls
-
Total Puts
-
Put-Call Ratio
0.00
change: -292.1975 | last: 2.922
Total Invested
111.82M
Beneficial Ownership Filings
| Filing Date | Reporting Person | Amount Beneficially Owned | % of Class |
|---|---|---|---|
| 2026-07-27 | BlackRock, Inc. | 3.54M | 5.40% |
| 2026-05-15 | Vestal Point Capital, LP | 5.42M | 8.30% |
| 2026-05-15 | JANUS HENDERSON GROUP PLC | 3.34M | 5.10% |
| 2026-05-15 | Deep Track Capital, LP | 4.06M | 6.21% |
| 2026-05-08 | Red Tree GP, LLC | 3.17M | 4.80% |
| 2026-05-06 | FMR LLC | 2.1M | 3.20% |
| 2026-04-08 | T. Rowe Price Investment Management, Inc. | 6.61M | 10.10% |
| 2026-03-02 | Peter Kolchinsky | 7.28M | 11.50% |
| 2026-03-02 | Rajeev Shah | 7.28M | 11.50% |
| 2026-03-02 | RA Capital Management, L.P. | 7.28M | 11.50% |
| 2026-03-02 | RA Capital Healthcare Fund, L.P. | 4.6M | 7.30% |
| 2026-02-17 | T. Rowe Price Investment Management, Inc. | 3.24M | 5.90% |
| 2026-02-17 | Vestal Point Capital, LP | 3.58M | 6.50% |
| 2026-02-12 | Deep Track Capital, LP | 2.75M | 5.02% |
| 2026-02-05 | FMR LLC | 3.35M | 6.10% |
| 2025-08-14 | Vestal Point Capital, LP | 5M | 9.20% |
| 2025-07-17 | FMR LLC | 2.76M | 5.10% |
| 2025-07-17 | FMR LLC | 2.54M | 4.70% |
| 2025-05-15 | Vestal Point Capital, LP | 2.77M | 5.10% |
| 2025-05-12 | FMR LLC | 3.61M | 6.60% |
| 2025-03-03 | FMR LLC | 2.8M | 5.20% |
| 2025-02-12 | FMR LLC | 2.12M | 3.90% |
| 2024-09-26 | 13G | 31541.0 | 0.10% |
| 2024-09-26 | 13G | 3.07M | 5.70% |
| 2024-09-26 | 13G | 3.04M | 5.60% |
| 2024-09-26 | 13G | 3.04M | 5.60% |
| 2024-09-26 | Heath Lukatch | 3.17M | 5.80% |
| 2024-09-26 | Red Tree Venture Fund, L.P. | 3.17M | 5.80% |
| 2024-09-26 | Red Tree GP, LLC | 3.17M | 5.80% |
| 2024-09-26 | 13G | 31541.0 | 0.10% |
| 2024-09-26 | 13G | 3.04M | 5.60% |
| 2024-09-26 | 13G | 31541.0 | 0.10% |
| 2024-09-26 | 13G | 3.04M | 5.60% |
| 2024-09-23 | Peter Kolchinsky | 6.96M | 12.80% |
| 2024-09-23 | RA Capital Healthcare Fund, L.P. | 4.3M | 7.90% |
| 2024-09-23 | Rajeev Shah | 6.96M | 12.80% |
| 2024-09-23 | RA Capital Management, L.P. | 6.96M | 12.80% |
| 2024-09-18 | FMR LLC | 2.5M | 5.10% |
| 2024-09-18 | Jon Winkelried | 3.01M | 5.50% |
| 2024-09-18 | TPG GP A, LLC | 3.01M | 5.50% |
| 2024-09-18 | James G. Coulter | 3.01M | 5.50% |
| 2024-09-18 | David Bonderman | 3.01M | 5.50% |
| 2024-09-18 | Abigail P. Johnson | 2.5M | 5.10% |
BCAX Enterprise Value History
Annual
| Date | Stock Price | Shares Outstanding | Market Cap | Cash & Equivalents | Total Debt | Enterprise Value |
|---|---|---|---|---|---|---|
| 2025-12-31 | $16.83 | 54.68M | $920.21M | $96.68M | $1.71M | $825.24M |
| 2024-12-31 | $17.42 | 54.42M | $948.08M | $489.71M | $738K | $459.11M |
| 2023-12-31 | $23.41 | 51.76M | $1.21B | $230.44M | $657K | $981.94M |
| 2022-12-31 | $23.41 | 51.76M | $1.21B | $4.16M | -$ | $1.21B |
Quarterly
| Date | Stock Price | Shares Outstanding | Market Cap | Cash & Equivalents | Total Debt | Enterprise Value |
|---|---|---|---|---|---|---|
| 2026-03-31 | $19.89 | 60.72M | $1.21B | $323.46M | $1.44M | $885.64M |
| 2025-12-31 | $16.83 | 55.14M | $928.04M | $96.68M | $1.71M | $833.07M |
| 2025-09-30 | $15.79 | 54.56M | $861.56M | $171.67M | $1.98M | $691.87M |
| 2025-06-30 | $9.29 | 54.54M | $506.67M | $436.61M | $2.24M | $72.3M |
| 2025-03-31 | $13.03 | 54.46M | $709.57M | $462.06M | $591K | $248.09M |
| 2024-12-31 | $17.42 | 54.44M | $948.35M | $489.71M | $738K | $459.37M |
| 2024-09-30 | $25.47 | 54.41M | $1.39B | $520.76M | $445K | $865.5M |
| 2024-06-30 | $23.41 | 54.18M | $1.27B | $203.86M | $517K | $1.07B |
| 2024-03-31 | $23.41 | 54.18M | $1.27B | $203.86M | $517K | $1.07B |
| 2023-12-31 | $23.41 | 53.09M | $1.24B | $230.44M | $657K | $1.01B |
| 2023-09-30 | $23.41 | 54.41M | $1.27B | -$ | -$ | $1.27B |
| 2023-06-30 | $23.41 | 54.6M | $1.28B | -$ | -$ | $1.28B |